Question 1

What specific information will be gathered from the alpha1-antitrypsin level test?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Maternal alpha1 Antitrypsin as a Marker of Intrauterine Growth Restriction in Pre-eclamptic Women clinical trial (NCT05622838). Contact the study team or your healthcare provider for specific answers.

Question 2

How will my participation in this study help improve care for other pregnant women?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Maternal alpha1 Antitrypsin as a Marker of Intrauterine Growth Restriction in Pre-eclamptic Women clinical trial (NCT05622838). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential risks or discomforts associated with participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Maternal alpha1 Antitrypsin as a Marker of Intrauterine Growth Restriction in Pre-eclamptic Women clinical trial (NCT05622838). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to visit for this study, and what will those visits involve?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Maternal alpha1 Antitrypsin as a Marker of Intrauterine Growth Restriction in Pre-eclamptic Women clinical trial (NCT05622838). Contact the study team or your healthcare provider for specific answers.

Question 5

Will my participation affect my current pregnancy care or treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Maternal alpha1 Antitrypsin as a Marker of Intrauterine Growth Restriction in Pre-eclamptic Women clinical trial (NCT05622838). Contact the study team or your healthcare provider for specific answers.

What this study is about